Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in <i>Apoe</i><sup>−/−</sup> Mice-Reference-Cited by-同舟云学术

Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apoe^−/− Mice

Published:2022-01-01 Issue:1 Volume:29 Page:111-125
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Katsuki Shunsuke¹,Koga Jun-ichiro¹,Matoba Tetsuya¹,Umezu Ryuta¹,Nakashiro Soichi¹,Nakano Kaku²,Tsutsui Hiroyuki¹,Egashira Kensuke²

Affiliation:

1. The Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University

2. The Department of Cardiovascular Research, Development, and Translational Medicine, Center for Disruptive Cardiovascular Innovation, Kyushu University

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/29/1/29_54379/_pdf

Reference51 articles.

1. 1) Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Statistics C and Stroke Statistics S. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation, 2017; 135: e146-e603

2. 2) Powell JT, Brady AR, Brown LC, Forbes JF, Fowkes FGR, Greenhalgh RM, Ruckley CV, Thompson SG and Participants USAT. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet, 1998; 352: 1649-1655

3. 3) De Bruin JL, Baas AF, Buth J, Prinssen M, Verhoeven ELG, Cuypers PWM, van Sambeek MRHM, Balm R, Grobbee DE, Blankensteijn JD and Grp DS. Long-Term Outcome of Open or Endovascular Repair of Abdominal Aortic Aneurysm. New Engl J Med, 2010; 362: 1881-1889

4. 4) Greenhalgh RM, Brown LC, Powell JT, Thompson SG and Epstein D. Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med, 2010; 362: 1872-1880

5. 5) Lederle FA, Freischlag JA, Kyriakides TC, Matsumura JS, Padberg FT, Kohler TR, Kougias P, Jean-Claude JM, Cikrit DF, Swanson KM and Study OVAC. Long-Term Comparison of Endovascular and Open Repair of Abdominal Aortic Aneurysm. New Engl J Med, 2012; 367: 1988-1997

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating Natural Deep Eutectic Solvents into Nanostructured Lipid Carriers: An Industrial Look;Pharmaceuticals;2024-06-28

2. Diagnostic value of uric acid to high-density lipoprotein cholesterol ratio in abdominal aortic aneurysms;Annals of Medicine;2024-05-23

3. Multiscale physics-based in silico modelling of nanocarrier-assisted intravascular drug delivery;Frontiers in Drug Delivery;2024-03-04

4. A REVIEW OF ABDOMINAL AORTIC ANEURYSMS: RISK FACTORS, SCREENING, PHARMACOLOGICAL APPROACH;FARMACIA;2024

5. The future for the therapeutics of abdominal aortic aneurysm: engineered nanoparticles drug delivery for abdominal aortic aneurysm;Frontiers in Bioengineering and Biotechnology;2024-01-05